163 related articles for article (PubMed ID: 38166611)
1. Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study.
Fang C; Xu C; Jia X; Li X; Yin C; Xing X; Li W; Wang Z
BMC Gastroenterol; 2024 Jan; 24(1):1. PubMed ID: 38166611
[TBL] [Abstract][Full Text] [Related]
2. Establishment and external validation of prognosis prediction nomogram for patients with distant metastatic intrahepatic cholangiocarcinoma: based on a large population.
Yuan C; Zou S; Wang K; Hu Z
BMC Cancer; 2024 Feb; 24(1):227. PubMed ID: 38365630
[TBL] [Abstract][Full Text] [Related]
3. Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression.
Wang W; Ji W; Lyu Z; Sun W; Shao Y; Liu J; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):98-107. PubMed ID: 38105682
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
[No Abstract] [Full Text] [Related]
6. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma.
Wang W; Wu C; Xu L; Li P; Wang K; Li G; Zhao S; Li Y; Fan X; Wang W; Hu M; Wu J; Xu S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9577-9586. PubMed ID: 37222808
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of HTS grade in patients with intrahepatic cholangiocarcinoma undergoing radical resection: a multicenter study from China.
Huang G; Zhang H; Yang Z; Li Q; Yuan H; Chen P; Xie C; Meng B; Zhang X; Chen K; Yu H
World J Surg Oncol; 2024 Jan; 22(1):17. PubMed ID: 38200585
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy.
Song J; Di Y; Kang X; Ren G; Wang Y
Front Public Health; 2023; 11():1012069. PubMed ID: 36817916
[TBL] [Abstract][Full Text] [Related]
10. A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.
Wang Y; Zhou CW; Zhu GQ; Li N; Qian XL; Chong HH; Yang C; Zeng MS
Ann Transl Med; 2021 Oct; 9(20):1518. PubMed ID: 34790724
[TBL] [Abstract][Full Text] [Related]
11. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
[TBL] [Abstract][Full Text] [Related]
12. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
15. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
[No Abstract] [Full Text] [Related]
16. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
17. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
18. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.
Guo K; Lou Y; Zheng S
Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724
[TBL] [Abstract][Full Text] [Related]
19. Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.
Zheng C; Gu XT; Huang XL; Wei YC; Chen L; Luo NB; Lin HS; Jin-Yuan L
Radiol Med; 2023 Dec; 128(12):1460-1471. PubMed ID: 37747668
[TBL] [Abstract][Full Text] [Related]
20. A Visualized Dynamic Prediction Model for Lymphatic Metastasis in Ewing's Sarcoma for Smart Medical Services.
Li W; Xu C; Hu Z; Dong S; Wang H; Liu Q; Tang ZR; Li W; Wang B; Lei Z; Yin C
Front Public Health; 2022; 10():877736. PubMed ID: 35602163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
